Methods and compositions for use with K-ras mediated disorders
US9474730B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2013 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | Aug 25, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions that can be used to identify and characterize inhibitors of K-ras localization to the plasma membrane and in doing so inhibit the signal transduction of K-ras. Such compositions can be used to treat K-ras mediated disorders, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.